() E2F6

Xinyi Zheng1, Shengying Qin2, Mingkang Zhong1

  • 1Department of Pharmacy, Huashan Hospital, Fudan University, 12 Middle Urumqi Road, Shanghai 200040, China.

Biomedicines
|January 8, 2025
PubMed
概括

一种新的PPP3R1基因多态,rs4519508 C > T,通过改变转录因子结合来影响塔克罗利 (TAC) 免疫抑制. 这种遗传变异可能解释了患者对TAC治疗反应的个体差异.